HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kenneth C Anderson Selected Research
Kenneth C Anderson Research Topics
Disease
535
Multiple Myeloma
05/2024 - 01/2002
264
Neoplasms (Cancer)
04/2024 - 01/2002
34
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2023 - 04/2003
32
Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 04/2002
18
Disease Progression
01/2022 - 06/2005
17
Thrombocytopenia (Thrombopenia)
01/2024 - 05/2002
16
Lymphoma (Lymphomas)
01/2022 - 04/2003
11
Neutropenia
01/2022 - 12/2004
10
Anemia
01/2023 - 01/2009
10
Plasmacytoma
01/2017 - 09/2002
10
Peripheral Nervous System Diseases (PNS Diseases)
12/2015 - 07/2006
9
Residual Neoplasm
01/2024 - 11/2016
8
Fatigue
01/2022 - 07/2006
8
Leukemia
10/2019 - 04/2002
8
Bone Diseases (Bone Disease)
01/2019 - 01/2002
6
Carcinogenesis
01/2019 - 10/2007
6
Chromosomal Instability (Chromosome Stability)
09/2015 - 01/2002
5
Breast Neoplasms (Breast Cancer)
08/2021 - 02/2011
5
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2011 - 07/2005
4
Chromosome Aberrations (Chromosome Abnormalities)
01/2024 - 09/2012
4
B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 04/2002
4
Bites and Stings (Sting)
01/2022 - 06/2020
4
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 07/2006
Drug/Important Bio-Agent (IBA)
152
Bortezomib (Velcade)
FDA Link
03/2024 - 05/2002
77
Proteasome Inhibitors
IBA
03/2024 - 05/2002
71
Dexamethasone (Maxidex)
FDA Link
Generic
02/2024 - 02/2002
67
Lenalidomide (CC 5013)
FDA Link
11/2023 - 11/2002
43
Proteins (Proteins, Gene)
FDA Link
03/2024 - 03/2002
40
Thalidomide (Thalomid)
FDA Link
01/2021 - 04/2002
37
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2023 - 10/2002
28
Monoclonal Antibodies
IBA
02/2024 - 04/2003
28
Interleukin-6 (Interleukin 6)
IBA
10/2021 - 01/2002
27
Immunomodulating Agents
IBA
11/2021 - 05/2002
26
Cytokines
IBA
03/2024 - 01/2002
24
Melphalan (Alkeran)
FDA Link
Generic
05/2024 - 07/2002
24
Antigens
IBA
04/2024 - 04/2003
23
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016 - 02/2002
20
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
12/2023 - 05/2005
18
NF-kappa B (NF-kB)
IBA
07/2013 - 05/2002
16
pomalidomide
IBA
02/2024 - 09/2006
14
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 03/2003
13
Histone Deacetylase Inhibitors
IBA
04/2024 - 04/2003
12
Biomarkers (Surrogate Marker)
IBA
11/2023 - 10/2007
11
Peptides (Polypeptides)
IBA
01/2021 - 06/2003
11
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021 - 03/2002
10
Histone Deacetylases (Histone Deacetylase)
IBA
04/2024 - 10/2003
10
B-Cell Maturation Antigen
IBA
03/2024 - 07/2006
10
Immunoglobulins (Immunoglobulin)
IBA
12/2023 - 03/2002
10
Ubiquitin
IBA
01/2023 - 08/2006
10
Immunoconjugates (Immunoconjugate)
IBA
12/2021 - 07/2004
10
perifosine
IBA
07/2020 - 05/2006
10
MicroRNAs (MicroRNA)
IBA
01/2020 - 04/2009
10
Enzymes
IBA
01/2018 - 10/2003
10
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2014 - 01/2003
9
Telomerase (Telomerase Reverse Transcriptase)
IBA
03/2024 - 01/2002
9
Heat-Shock Proteins (Heat-Shock Protein)
IBA
02/2024 - 10/2002
9
Phosphotransferases (Kinase)
IBA
12/2017 - 03/2004
8
daratumumab
IBA
02/2024 - 02/2011
8
Alkylating Agents
IBA
01/2023 - 08/2006
8
Immunoglobulin M (IgM)
IBA
01/2023 - 04/2003
8
elotuzumab
IBA
12/2021 - 08/2008
8
Ligands
IBA
10/2021 - 03/2002
8
Vorinostat
FDA Link
01/2016 - 04/2003
8
tanespimycin (17AAG)
IBA
12/2011 - 02/2006
8
Insulin-Like Growth Factor I (IGF-1)
IBA
01/2009 - 08/2002
7
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
03/2024 - 01/2003
7
Histones (Histone)
IBA
01/2023 - 05/2009
7
carfilzomib
IBA
10/2020 - 07/2013
7
Prednisone (Sone)
FDA Link
Generic
01/2018 - 08/2005
7
Immunoglobulin G (IgG)
IBA
07/2014 - 07/2005
7
Rituximab (Mabthera)
FDA Link
09/2010 - 01/2005
7
Antineoplastic Agents (Antineoplastics)
IBA
05/2010 - 09/2002
6
isatuximab
IBA
02/2024 - 08/2017
6
Messenger RNA (mRNA)
IBA
01/2021 - 04/2002
6
Antibodies
IBA
11/2019 - 03/2002
6
marizomib
IBA
09/2016 - 11/2005
6
Panobinostat
IBA
10/2013 - 11/2011
6
Caspases
IBA
06/2013 - 11/2003
6
Glucocorticoids
IBA
07/2012 - 01/2005
6
Cytotoxins (Cytolysins)
IBA
04/2009 - 07/2004
6
Interleukins
IBA
01/2009 - 05/2004
6
Insulin-Like Peptides
IBA
01/2009 - 01/2002
5
Insulin (Novolin)
FDA Link
03/2024 - 08/2002
5
Oligonucleotides
IBA
03/2024 - 02/2002
5
Complement System Proteins (Complement)
IBA
01/2020 - 04/2003
5
ixazomib
IBA
01/2018 - 08/2011
5
Zoledronic Acid (Zometa)
FDA Link
03/2016 - 02/2009
5
Sirolimus (Rapamycin)
FDA Link
11/2014 - 12/2004
5
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
12/2012 - 06/2005
5
enzastaurin
IBA
07/2011 - 02/2007
5
Protein Kinase C
IBA
02/2009 - 05/2004
4
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2024 - 09/2012
4
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2023 - 06/2003
4
Chimeric Antigen Receptors
IBA
12/2021 - 11/2019
Therapy/Procedure
207
Therapeutics
01/2024 - 01/2002
28
Drug Therapy (Chemotherapy)
03/2024 - 01/2002
22
Stem Cell Transplantation
01/2023 - 01/2002
22
Immunotherapy
01/2022 - 06/2003
11
Transplantation
01/2022 - 01/2002
4
Precision Medicine
12/2021 - 10/2015